Jill Marie Broadfoot - 31 May 2024 Form 4 Insider Report for aTYR PHARMA INC (ATYR)

Signature
/s/ Nancy E. Denyes, as Attorney-in-Fact
Issuer symbol
ATYR
Transactions as of
31 May 2024
Net transactions value
+$8,950
Form type
4
Filing time
03 Jun 2024, 08:38:39 UTC
Previous filing
06 Feb 2024
Next filing
24 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIFE Common Stock Purchase $8,950 +5,000 +22% $1.79 27,960 31 May 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 2,139 shares acquired on May 15, 2024 under the Company's 2015 Employee Purchase Plan.